Illinois BioNanotechnology Seminar Series Fall 2011: Directed Blood Vessel Growth Using an Angiogenic Microfiber/Microparticle Composite Patch
Licensed according to this deed.
No results found.
Therapeutic angiogenesis has emerged as a promising strategy to treat various acute and chronic vascular diseases, and to enhance tissue repair and regeneration. Common revascularization therapies include the administration of angiogenic factors, such as vascular endothelial growth factor (VEGF). The success of these therapies greatly relies on the ability to control the spatial organization of mature and functional neovessels at physiologically relevant micrometer scales; however, there is a lack of biomedical devices that control the directional growth and spacing of blood vessels. The objective of this study was to develop an angiogenic patch that releases angiogenic growth factors and ultimately regulates the directional growth of mature and functional blood vessels.
Tuesday, October 4, 2011
1000 MNTL, 12:20 - 12:40 PM
University of Illinois at Urbana-Champaign
Midwest Cancer Nanotechnology Training Center
Center for Nanoscale Science and Technology
Researchers should cite this work as follows:
Ross J DeVolder; Zuhaib Bashir Sheikh (2011), "Illinois BioNanotechnology Seminar Series Fall 2011: Directed Blood Vessel Growth Using an Angiogenic Microfiber/Microparticle Composite Patch ," https://nanohub.org/resources/12443.